We develop evaluation methods for the drug release functions of formulations, such as rapid release tablets, combination tablets, orally disintegrating tablets, and sustained release formulations using various dissolution test apparatus, various artificial gastric juices and intestinal fluids, to support the prediction of drug absorption in the body.
SPERA provides CMC solutions from early-stage through new drug application.
Contact USpage top